Dr. Jefferson M. Prichard

Claim this profile

Sentara Martha Jefferson Hospital

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
1 drug studied

Area of expertise

1Lung Cancer
Jefferson M. Prichard has run 1 trial for Lung Cancer. Some of their research focus areas include:
Stage I
Stage II
ALK positive
2Non-Small Cell Lung Cancer
Jefferson M. Prichard has run 1 trial for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage I
Stage II
ALK positive

Affiliated Hospitals

Image of trial facility.
Sentara Martha Jefferson Hospital

Clinical Trials Jefferson M. Prichard is currently running

Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria

More about Jefferson M. Prichard

Clinical Trial Related9 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Jefferson M. Prichard has experience with
  • Crizotinib
Breakdown of trials Jefferson M. Prichard has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
ALK Gene Rearrangement

Other Doctors you might be interested in

Andrew M. RomanoSentara Martha Jefferson Hospital
Joseph Newton, MDSentara Norfolk General Hospital

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jefferson M. Prichard specialize in?
Jefferson M. Prichard focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage I patients, or patients who are Stage II.
Is Jefferson M. Prichard currently recruiting for clinical trials?
Yes, Jefferson M. Prichard is currently recruiting for 1 clinical trial in Charlottesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Jefferson M. Prichard has studied deeply?
Yes, Jefferson M. Prichard has studied treatments such as Crizotinib.
What is the best way to schedule an appointment with Jefferson M. Prichard?
Apply for one of the trials that Jefferson M. Prichard is conducting.
What is the office address of Jefferson M. Prichard?
The office of Jefferson M. Prichard is located at: Sentara Martha Jefferson Hospital, Charlottesville, Virginia 22901 United States. This is the address for their practice at the Sentara Martha Jefferson Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top